Zobrazeno 1 - 10
of 161
pro vyhledávání: '"F A, Larkin"'
Autor:
Jahanzaib Khwaja, Joshua Bomsztyk, Shameem Mahmood, Brendan Wisniowski, Raakhee Shah, Anish Tailor, Kwee Yong, Rakesh Popat, Neil Rabin, Charalampia Kyriakou, Jonathan Sive, Simona Degli Esposti, Daniel F. P. Larkin, Sarah Worthington, Alyse Hart, Emma Dowling, Nuno Correia, Ceri Bygrave, Andrzej Rydzewski, Krzysztof Jamroziak, Ashutosh D. Wechalekar
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 9, Pp 1-3 (2022)
Externí odkaz:
https://doaj.org/article/e4d4b37586d0442ea1202150bfb9a084
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-8 (2020)
Abstract Background The KERALINK trial tests the hypothesis that corneal cross-linking (CXL) treatment reduces the progression of keratoconus in comparison to standard care in patients aged 10–16 years. This article describes the statistical analys
Externí odkaz:
https://doaj.org/article/b397b57bf72a42cb852dd68593f34e34
Autor:
Su Yin Koay, Daniel F. P. Larkin
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Neurotrophic keratitis (NK) is a rare degenerative condition that is caused by damage to the trigeminal nerve, with partial or complete loss of corneal sensory innervation. The loss of innervation leads to impaired healing of corneal epithelium, whic
Externí odkaz:
https://doaj.org/article/985893036f5849119840eef83ba3dc40
Autor:
Catey Bunce, Caroline Doré, Daniel F P Larkin, Kashfia Chowdhury, Jennifer M Burr, Mathew Raynor, Matthew Edwards
Publikováno v:
BMJ Open, Vol 9, Iss 9 (2019)
Introduction The KERALINK trial tests the hypothesis that corneal cross-linking (CXL) treatment reduces the progression of keratoconus in comparison to standard care in patients under 17 years old. KERALINK is a randomised controlled, observer-masked
Externí odkaz:
https://doaj.org/article/d9449d48a3604165964c93d6d5578bd8
Publikováno v:
Eye. 37:1236-1241
To compare Kaplan-Meier survival curves and funnel plots for the audit of surgeon-specific corneal transplantation outcomes.We obtained data on all patients with Fuchs endothelial dystrophy (FED) receiving a first corneal transplant in one eye betwee
Autor:
Augusto Azuara-Blanco, Aaron Carlisle, Hari Jayaram, Gus Gazzard, Daniel F. P. Larkin, Louisa Wickham, Noemi Lois, Amanda Bicket
Publikováno v:
Azuara-Blanco, A, Carlisle, A, Jayaram, H, Gazzard, G, Larkin, D F P, Wickham, L, Lois, N & Bicket, A 2022, ' Surgical innovation in ophthalmology: challenges and opportunities ', Eye . https://doi.org/10.1038/s41433-022-02324-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c42f5bd346132e1a1a44edd1c162f77
https://pure.qub.ac.uk/en/publications/3cb9f004-84e4-4ede-b695-574f4bded6cb
https://pure.qub.ac.uk/en/publications/3cb9f004-84e4-4ede-b695-574f4bded6cb
Publikováno v:
American Journal of Ophthalmology. 226:68-75
Purpose To examine pretransplant findings and outcomes of corneal transplants for keratoconus in children. Design Retrospective cohort (national registry) study. Methods Data on all patients aged 16 or younger (n = 170) who had a first transplant for
Publikováno v:
The British Journal of Ophthalmology
AimWe report two cases of endothelial corneal allograft rejection following immunisation with SARS-CoV-2 messenger RNA (mRNA) vaccine BNT162b2 and describe the implications for management of transplant recipients postvaccination for COVID-19.MethodsA
Autor:
Daniel F P, Larkin, Kashfia, Chowdhury, Jennifer M, Burr, Mathew, Raynor, Matthew, Edwards, Stephen J, Tuft, Catey, Bunce, Emilia, Caverly, Caroline, Doré, Colin, Willoughbys
Supported by the National Institute for Health Research (NIHR ) Efficacy and Mechanism Evaluation Programme (grant no.: 14/23/18), a Medical Research Council and NIHR partnership. It was coordinated by University College London’s Comprehensive Clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8917d9bcd401c44844dbf7a7c0a1daae
https://hdl.handle.net/10023/24399
https://hdl.handle.net/10023/24399
Publikováno v:
British Journal of Ophthalmology. 104:729-734
AimsTo investigate the relative risk of pretransplant corneal vascularisation on rate of rejection and graft failure within 5 years of surgery when categorised by indication for transplantation.We analysed all adults recorded in the UK transplant reg